PATANASE
- Product NDC
- 0078-0834
- 11-digit product format
- 000780834
- Labeler code
- 0078
- Product ID
- 0078-0834_3cbeda75-be25-4d55-83ea-ace367ab7332
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- olopatadine hydrochloride
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA021861
- Marketing category
- NDA
- Marketing start
- 2008-04-28
- Marketing end
- 0000-00-00
- Substance
- OLOPATADINE HYDROCHLORIDE
- Active strength
- 600 ug/1
- Pharmacologic classes
- Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0834-30 | 00078083430 | 1 BOTTLE in 1 CARTON (0078-0834-30) > 240 SPRAY, METERED in 1 BOTTLE | 1 bottle | 2021-12-24 | 0000-00-00 | No | No | Current |